Hepatitis B infection remains a leading cause of cirrhosis and liver cancer worldwide. In the U.S., the prevalence is estimated at 0.3-0.5% of the population. An updated look at the epidemiology comes from NYC (MMWR 2012; 61: 6-9). Investigators randomly selected 180 HBV cases (2008-2010) and investigated them.
- Two-thirds were Asian.
- In 70%, the clinician did not know any of patient risk factors
- In 62%, the clinician did not know hepatitis A vaccination status (despite recommendations)
- Main reasons for testing: 27% birth country prevalence, 12% elevated liver tests, 2% hepatitis signs/symptoms
- Only 75% received counseling regarding transmission
As a result of this investigation, the department of health initiated multiple changes:
- Clinicians were contacted regarding HAV vaccinations
- Booklet for patients developed: How to Tell Others You Have Chronic Hepatits B
- Patient education booklet developed: Hepatitis B: the Facts
These booklets (in five languages) can be ordered in bulk and free of charge within NYC and also online at
Other useful links:
Previous related blog entries:
Unrelated link -but worth a look (thanks to Larry Saripkin for showing me this useful training video):
“dont go ninjin nobody that dont need ninjin” Kung Fu Hillbilly – Training Video – YouTube